Affiliation: Hospital Universitari Vall d'Hebron
- Outcome of patients following hepatic resection for metastatic cutaneous and ocular melanomaMireia Caralt
Department of Hepatobiliopancreatic Surgery and Transplants, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Passeig Vall d Hebron 119 129, 08035 Barcelona, Spain
J Hepatobiliary Pancreat Sci 18:268-75. 2011..The aim of this study was to analyze the outcome of patients undergoing hepatic resection for melanoma liver metastases...
- Present and Future of Regenerative Medicine: Liver TransplantationM Caralt
Servei Cirurgia Hepatobiliopancreàtica i Trasplants, Hospital Universitari Vall Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain Electronic address
Transplant Proc 47:2377-9. 2015..However, viability of these transplanted scaffolds is poor owing to the formation of thrombosis. We analyzed the recent advances in decellularizing and recellularizing and the results after transplantation reported in the literature. ..
- Hepatic resection for liver metastases as part of the "oncosurgical" treatment of metastatic breast cancerMireia Caralt
Department of Hepatobiliopancreatic Surgery and Transplants, Hospital Universitari Vall d Hebron, Paseo Vall d Hebron119 129, Barcelona, 08035, Spain
Ann Surg Oncol 15:2804-10. 2008..Metastatic breast cancer is considered an incurable disease despite new therapies. Recent studies suggest that liver resection associated with systemic treatment may improve patient survival...
- Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basisGonzalo Sapisochin
Department of HBP Surgery and Transplantation, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
Ann Surg Oncol 20:1194-202. 2013..We aimed to assess the long-term outcome of cirrhotic patients with single HCC ≤5 cm treated either with LR or LT on an intention-to-treat basis...
- Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centreGonzalo Sapisochin
Department of Hepatobiliopancreatic Surgery and Transplantation, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
Hepatol Int 5:707-15. 2011..The long-term outcome of patients developing de novo neoplasm (DN) at our centre was evaluated...
- Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European seriesGonzalo Sapisochin
HBP Surgery and Transplantation Department, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Passeig de la Vall d Hebron 119 129, 08035 Barcelona, Spain
World J Surg 34:2146-54. 2010..The aim of this study was to ascertain the outcome of liver transplantation (LT) due to hepatocellular carcinoma (HCC) in patients who had undergone previous liver resection (LR) for HCC...
- Does Matching Donor-Recipient Age Affect Long-Term Survival in Liver Transplantation?Cristina Dopazo
Department of HPB Surgery and Transplants, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
Ann Transplant 21:708-716. 2016..40, p 0.074) and <60 years (HR 1.47, p 0.070). CONCLUSIONS Older donor age did not negatively affect survival regardless of recipient age, and comparable outcomes were achieved without an increased rate of complications...
- Isolated bilateral Tapia's syndrome after liver transplantation: A case report and review of the literatureItxarone Bilbao
Itxarone Bilbao, Cristina Dopazo, Mireia Caralt, Lluis Castells, Elisabeth Pando, Amaia Gantxegi, Ramón Charco, Department of Digestive Surgery, Hepatobiliopancreatic Surgery and Liver Transplant Unit, Hospital Universitario Vall d Hebron, CIBERehd, Universidad Autonoma de Barcelona, 08035 Barcelona, Spain
World J Hepatol 8:1637-1644. 2016..To describe one case of bilateral Tapia's syndrome in a liver transplanted patient and to review the literature...
- Safety of bevacizumab in metastatic breast cancer patients undergoing surgeryJavier Cortes
Department of Oncology, Vall d Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
Eur J Cancer 48:475-81. 2012..Evaluate the safety of surgery in relation to bevacizumab in the first-line treatment of metastatic breast cancer (mBC) in two international trials...